iSpecimen board member Joseph Basile resigns; committee vacancies filled

iSpecimen Inc.

Joseph J. Basile resigned from the Board, effective Dec 31, 2023, and from audit and nominating committees.
Theresa L. Mock appointed to audit committee (Jan 1, 2024); deemed independent under Nasdaq rules.
Steven Gullans added to nominating and corporate governance committee; Mock named chair of that committee.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Joseph J. Basile

Director

ISPC · iSpecimen Inc.

Effective: 2023-12-31
Filed: December 21, 2023, 6:59 PM ET

On December 15, 2023, iSpecimen Inc. (the “Company”) received a letter of resignation from Joseph J. Basile to resign as a member of the Board of Directors of the Company (the “Board”), effective December 31, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Joseph J. Basile resigned as Director at iSpecimen Inc..

Action: resigned
Role: Director

Exact text from the filing

On December 15, 2023, iSpecimen Inc. (the “Company”) received a letter of resignation from Joseph J. Basile to resign as a member of the Board of Directors of the Company (the “Board”), effective December 31, 2023.

View on SEC.gov

iSpecimen Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-128217

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.